Skip to main content
Book cover

Hypertension and Renal Organ Damage

  • Book
  • © 2018

Overview

  • Presents the daily clinical practice setting of high-risk patients with hypertension-related kidney damage
  • In-depth review of antihypertensive treatments in highly comorbid patients - with a particular focus on RAAS inhibitors and combination treatment
  • Reviews and discusses current guidelines on the evaluation and treatment of patients with hypertension and renal dysfunction

Part of the book series: Practical Case Studies in Hypertension Management (PCSHM)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

Keywords

About this book

This book guides readers through a wide spectrum of clinical presentations in patients with arterial hypertension and different degrees of renal impairment, ranging from asymptomatic urine abnormalities to end stage renal disease. On the basis of six case studies, the author reviews and discusses current guidelines and recommendations aimed at optimizing the diagnostic and therapeutic approach both to renal and cardiovascular risk in commonly encountered real-world clinical scenarios including challenging cases of diabetic kidney disease, ischemic nephropathy and resistant hypertension. It also explores anti-hypertensive drug combinations, including single or multiple RAAS-I, lipid lowering and antiplatelet drugs, as well as the appropriate use of glucose lowering drugs in the context of chronic kidney disease. This handy and practical book provides physicians in the area of general and internal medicine, as well as specialists in the cardiovascular, metabolic and renal fields valuable insights into optimal therapeutic targets for blood pressure and glucose control in renal patients.

Authors and Affiliations

  • University of Genoa, IRCCS Policlinico San Martino, Genoa, Italy

    Roberto Pontremoli

About the author

Roberto Pontremoli is Associate Professor of Medicine at the Department of Internal Medicine, University of Genoa Medical School, Italy. He is the chief of the Hypertension Unit at the University Medical School and San Martino Hospital in Genoa and has extensive experience as a clinical investigator in the field of renal and cardiovascular medicine. 
He is a European Society of Hypertension (ESH) specialist, a member of the directory board of the Italian Society of Hypertension and former secretary and founding member of the Italian Society of Nephro-Cardiology.
He further is an associate editor of scientific journals such as Internal and Emergency Medicine, the International Journal of Hypertension and editorial board member of the Journal of Hypertension and the Journal of Nephrology.
Prof. Pontremoli’s research interests include cardio-renal interactions in hypertension, albuminuria as a cardiovascular and renal risk marker and diabetic nephropathy. He is author orco-author of over 150 PudMed indexed publications in peer-reviewed journals.

Bibliographic Information

Publish with us